Ke. Brigle et al., INCREASED EXPRESSION AND CHARACTERIZATION OF 2 DISTINCT FOLATE BINDING-PROTEINS IN MURINE ERYTHROLEUKEMIA-CELLS, Biochemical pharmacology, 47(2), 1994, pp. 337-345
We previously identified two membrane-bound folate binding proteins, F
BP1 and FBP2, in murine L1210 leukemia cells. We now report on the dev
elopment of two variant murine erythroleukemia cell lines that were us
ed for direct comparison and biochemical characterization of the two m
urine folate binding proteins. Based on the results of northern analys
is and the mobilities of affinity-labeled proteins on polyacrylamide g
els, these cell lines exhibit specific up-regulated expression of FBP1
or FBP2. The affinities of the folate binding proteins for various (a
nti)folates were determined based upon the ability of the compounds to
inhibit binding of [H-3]folic acid. The two proteins exhibited consid
erably different affinities and stereospecificities and, in general, F
BP2 consistently bound each test compound with lesser affinity than FB
P1. Both proteins displayed greatest affinity for folic acid, 5-methyl
tetrahydrofolate, and the antifolates CB3717 and 5,10-dideazatetrahydr
ofolate (DDATHF). Conversely, the proteins exhibited poor affinity for
the dihydrofolate reductase inhibitors methotrexate and aminopterin.
For 5-formyltetrahydrofolate, FBP1 had high affinity for the (6S) dias
tereoisomer, whereas FBP2 showed preference for the non-physiologic (6
R) diastereoisomer. The binding properties of FBP1 and FBP2 overexpres
sed in these cell lines closely paralleled those of their respective h
uman homologs. These lines provide a model system in which to examine
the biochemical characteristics of the individual folate binding prote
ins without the potential problems associated with expression of prote
ins in dissimilar cell lines.